136 related articles for article (PubMed ID: 32682840)
1. Association of ZNF184, IL1R2, LRRK2, ITPKB, and PARK16 with sporadic Parkinson's disease in Eastern China.
Gao T; Zheng R; Ruan Y; Fang Y; Jin C; Cao J; Song Z; Tian J; Pu J; Zhang B
Neurosci Lett; 2020 Sep; 735():135261. PubMed ID: 32682840
[TBL] [Abstract][Full Text] [Related]
2. Association of ITPKB, IL1R2 and COQ7 with Parkinson's disease in Taiwan.
Fang HS; Wang CC; Chao CY; Fan WL; Su SC; Wu YR
J Formos Med Assoc; 2022 Mar; 121(3):679-686. PubMed ID: 34244037
[TBL] [Abstract][Full Text] [Related]
3. Association of
Li G; Cui S; Du J; Liu J; Zhang P; Fu Y; He Y; Zhou H; Ma J; Chen S
Front Aging Neurosci; 2018; 10():402. PubMed ID: 30618709
[No Abstract] [Full Text] [Related]
4. Assessment of three essential tremor genetic loci in sporadic Parkinson's disease in Eastern China.
Gao T; Wu J; Zheng R; Fang Y; Jin CY; Ruan Y; Cao J; Tian J; Pu JL; Zhang BR
CNS Neurosci Ther; 2020 Apr; 26(4):448-452. PubMed ID: 31755235
[TBL] [Abstract][Full Text] [Related]
5. Association of Parkinson's Disease GWAS-Linked Loci with Alzheimer's Disease in Han Chinese.
Zhu XC; Cao L; Tan MS; Jiang T; Wang HF; Lu H; Tan CC; Zhang W; Tan L; Yu JT
Mol Neurobiol; 2017 Jan; 54(1):308-318. PubMed ID: 26738859
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.
Wang L; Heckman MG; Aasly JO; Annesi G; Bozi M; Chung SJ; Clarke C; Crosiers D; Eckstein G; Garraux G; Hadjigeorgiou GM; Hattori N; Jeon B; Kim YJ; Kubo M; Lesage S; Lin JJ; Lynch T; Lichtner P; Mellick GD; Mok V; Morrison KE; Quattrone A; Satake W; Silburn PA; Stefanis L; Stockton JD; Tan EK; Toda T; Brice A; Van Broeckhoven C; Uitti RJ; Wirdefeldt K; Wszolek Z; Xiromerisiou G; Maraganore DM; Gasser T; Krüger R; Farrer MJ; Ross OA; Sharma M;
Neurobiol Aging; 2017 Jan; 49():217.e1-217.e4. PubMed ID: 27814993
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of 15 GWAS-linked loci with Parkinson's disease in Chinese Han population.
Hu X; Mao C; Hu Z; Zhang Z; Zhang S; Yang Z; Fan Y; Fan L; Zheng H; Yang J; Liu Y; Yuan Y; Wang Y; Shi C; Xu Y
Neurosci Lett; 2020 Apr; 725():134867. PubMed ID: 32165260
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
[TBL] [Abstract][Full Text] [Related]
9. ITPKB and ZNF184 are associated with Parkinson's disease risk in East Asians.
Chew EGY; Tan LCS; Au WL; Prakash KM; Liu J; Foo JN; Tan EK
Neurobiol Aging; 2020 Feb; 86():201.e15-201.e17. PubMed ID: 30814023
[TBL] [Abstract][Full Text] [Related]
10. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
[TBL] [Abstract][Full Text] [Related]
11. Association of IL1R2 rs34043159 with sporadic Alzheimer's disease in southern Han Chinese.
Chen K; Tang Y; Zhao X; Hou C; Li G; Zhang B
Eur J Neurol; 2020 Oct; 27(10):1844-1847. PubMed ID: 32402117
[TBL] [Abstract][Full Text] [Related]
12. Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations.
Zhao H; Kong Z
Oncotarget; 2016 Jul; 7(30):46890-46898. PubMed ID: 27384489
[TBL] [Abstract][Full Text] [Related]
13. Analysis of rare variants of autosomal-dominant genes in a Chinese population with sporadic Parkinson's disease.
Zheng R; Jin CY; Chen Y; Ruan Y; Gao T; Lin ZH; Dong JX; Yan YP; Tian J; Pu JL; Zhang BR
Mol Genet Genomic Med; 2020 Oct; 8(10):e1449. PubMed ID: 32794657
[TBL] [Abstract][Full Text] [Related]
14. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.
Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W
Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603
[TBL] [Abstract][Full Text] [Related]
15. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of LRRK2 in Parkinson's disease in Han Chinese population.
Zhang JR; Jin H; Li K; Mao CJ; Yang YP; Wang F; Gu CC; Zhang HJ; Chen J; Liu CF
Neurobiol Aging; 2018 Dec; 72():187.e5-187.e10. PubMed ID: 30049590
[TBL] [Abstract][Full Text] [Related]
17. Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk.
Lake J; Reed X; Langston RG; Nalls MA; Gan-Or Z; Cookson MR; Singleton AB; Blauwendraat C; Leonard HL;
Mov Disord; 2022 Jan; 37(1):95-105. PubMed ID: 34542912
[TBL] [Abstract][Full Text] [Related]
18. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
[TBL] [Abstract][Full Text] [Related]
19. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
[TBL] [Abstract][Full Text] [Related]
20. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
Monfrini E; Di Fonzo A
Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
